Immunovant Job Trends

Immunovant logo
1
Active Jobs (Last 14 Days)
0
Fresh Jobs (Last 3 Days)
100%
Jobs with Salary Data

Recent Job Posting Activity (30 Days)

Immunovant 30-day hiring trend

Job Category Distribution

Immunovant job category distribution
Data spans Oct 14, 2026 through Nov 13, 2026, aggregated by PharmaPayWatch.com. Recent job postings shows the number of jobs posted each day (bars) for the past 30 days with an overlay of the 7 day running average. The rose plot shows how PharmaPayWatch categorizes those jobs to get a better sense of Immunovant's recent hiring focus. Note that some jobs aren't categorized by our filters, we exclude those from the rose plot.

Current Immunovant Jobs, Salary Data, and Stats

In the last two weeks, Immunovant has posted 1 positions. 100% of those roles offer remote or hybrid work. We've been tracking Immunovant since March 14, 2025.

Career Tracks Currently Hiring

Data Science Scientific Research Clinical Operations Quality & Regulatory Other Software & IT Commercial Medical Affairs Medical Practice

Currently Hiring Office Locations

Remote Hybrid - NYC Remote - Southeast New York, NY

Current Immunovant Jobs

Last updated: Nov 13, 2026

Showing 1 active jobs. Active jobs were posted in the last 14 days. Fresh jobs were posted within the last 3 days. Click a row for more details.

Role

Associate Director, Global Clinical Supply Chain

Remote Nov 9
$170,000 - $200,000
Remote
Apply →
Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in FcRn inhibitor technology, the Company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs. Associate Director, Global Clinical Supply Chain Reporting To Sr. Director, Global Supply Chain Location Flexible Work Environment Organizational Overview Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with...